Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
08/2004
08/26/2004WO2004071429A2 Lung inflammation treatment
08/26/2004WO2004071414A2 Therapeutic anti-hcv (al9) compounds
08/26/2004WO2004071178A2 Annexin and p34 promoters and use in expression of transgenic genes in plants
08/26/2004WO2004058392A3 Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups
08/26/2004WO2004058391A3 Photoactivatable two-stage protective groups for the synthesis of biopolymers
08/26/2004WO2004055160A3 Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry
08/26/2004WO2004045529A3 West nile virus vaccine
08/26/2004WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof
08/26/2004WO2004044141A8 Conjugated oligomeric compounds and their use in gene modulation
08/26/2004WO2004035819A3 Oligonucleotide analogues for detecting and analyzing nucleic acids
08/26/2004WO2004031208A3 Promoter sequences for corticotropin releasing factor binding protein and use thereof
08/26/2004WO2004020968A3 Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease
08/26/2004WO2004019002A3 Fluorescent glycosides and methods for their use
08/26/2004WO2004016755A3 Amplification of target nucleotide sequence without polymerase chain reaction
08/26/2004WO2004009018A3 Antisense modulation of ptprm expression
08/26/2004WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/26/2004WO2003035843A3 Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
08/26/2004WO2003035830A3 Efficient synthesis of protein-oligonucleotide conjugates
08/26/2004WO2003035829A3 Nanoparticles having oligonucleotides attached thereto and uses therefor
08/26/2004WO2003002633A9 Synthesis and use of organosilica particles
08/26/2004WO2001051003A3 Use of lipid conjugates in the treatment of disease
08/26/2004US20040168209 Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
08/26/2004US20040167324 Method for isolating and purifying nucleic acids
08/26/2004US20040167091 Methods for treating ocular neovascular diseases
08/26/2004US20040167089 Immunostimulatory nucleic acid molecules
08/26/2004US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases
08/26/2004US20040166570 Genes involved in polysaccharide production and utilization thereof
08/26/2004US20040166553 Caged sensors, regulators and compounds and uses thereof
08/26/2004US20040166529 Comprises electrophoretic tag (e-tag) probes for the multiplexed detection of binding or interactions between one or more ligands and target antiligands; biomolecular marker and signal resolution
08/26/2004US20040166527 Compositions and methods for the identification of lung tumor cells
08/26/2004US20040166525 Bioarray chip reaction apparatus and its manufacture
08/26/2004US20040166519 Using single nucleotide polymorphisms to diagnose cardiovascular and vascular disorders
08/26/2004US20040166515 Luminescent compounds
08/26/2004US20040166499 Nucleotide sequence polulation for priming, binding or annealing single strand polynucleotide and allowing the synthesis of a second polynucleotide complementary strand; microarray/biochip preparation
08/26/2004US20040166492 Quantitative detection of dekkera and saccharomyces
08/26/2004CA2515684A1 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
08/26/2004CA2515211A1 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine
08/26/2004CA2515039A1 Chemical treatment of biological samples for nucleic acid extraction and kits therefor
08/26/2004CA2514912A1 Rnai targeting of viruses
08/26/2004CA2513672A1 Terminal-phosphate-labeled nucleotides and methods of use
08/26/2004CA2512934A1 Short immunomodulatory oligonucleotides
08/26/2004CA2512588A1 Annexin promoter and its use in expression of transgenic genes in plants
08/25/2004EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
08/25/2004EP1449913A1 Gamma-glutamylcysteine-producing yeast
08/25/2004EP1449849A2 Protease-resistant thrombomodulin analog
08/25/2004EP1448986A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
08/25/2004EP1448800A2 Digital assay
08/25/2004EP1448799A2 Compositions and methods of selective nucleic acid isolation
08/25/2004EP1448795A1 Hybridization portion control oligonucleotide and its uses
08/25/2004EP1448793A1 Annealing control primer and its uses
08/25/2004EP1448776A1 Method for the isolation of nucleic acids
08/25/2004EP1027145A4 Apparatuses and methods for isolating nucleic acid
08/25/2004EP0839054B1 Tissue or cell-specific herpes simplex virus replication
08/25/2004EP0724632B1 Stem cell proliferation factor
08/25/2004EP0711361B1 5' nucleases derived from thermostable dna polymerase
08/25/2004CN1523110A Wheat glycogen synthetase kinase gene
08/25/2004CN1523034A Southern oligomycin biosynthetic gene cluster
08/25/2004CN1523033A Plasmid DNA purifying method by phase separation method
08/25/2004CN1163619C Method and composition for determining sequence of nucleic acid molecule
08/25/2004CN1163506C Novel human cell factor and its coding sequence and use
08/24/2004US6781001 Extended rhodamine dye compound suitable for the creating of sets of spactrally resolvable fluorescent labels particlularly useful for fluorescence based dna sequencing system
08/24/2004US6780989 Hybrid oligonucleotide
08/24/2004US6780988 Processes for producing P1,P4-diuridine-5′-tetraphosphate
08/24/2004US6780983 Polypeptide having water channel activity and DNA sequence
08/24/2004US6780981 Making a set of labelled compounds by the use of particulate support, comprises dividing the support into lots, performing a different chemical reaction on each lot of the support
08/24/2004US6780975 Long wavelength engineered fluorescent proteins
08/24/2004US6780642 Association of SIM2 with cancer
08/24/2004US6780609 High bone mass gene of 1.1q13.3
08/24/2004US6780585 Polymorphism analysis by nucleic and acid structure probing
08/24/2004US6780429 With 2'-5' phosphodiester bond content up to 3%; maintains pharmacological action while reducing toxicity
08/24/2004CA2111962C Amplification of target nucleic acids using gap filling ligase chain reaction
08/24/2004CA2074069C Primers and process for detecting human papillomavirus genotypes by pcr
08/24/2004CA2058632C Exonuclease-resistant oligonucleotides and methods for preparing the same
08/19/2004WO2004070061A1 Methods for nucleic acid analysis
08/19/2004WO2004070052A2 Compounds and processes for single-pot attachment of a label to nucleic acid
08/19/2004WO2004070015A2 Nematode pan and zp receptor-like sequences
08/19/2004WO2004070008A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
08/19/2004WO2004070007A2 Method for preparing single-stranded dna libraries
08/19/2004WO2004070006A2 Nucleic acid antigens embedded in thermoplastic
08/19/2004WO2004070005A2 Double ended sequencing
08/19/2004WO2004070004A2 Rat receptor tyrosine kinase, kdr
08/19/2004WO2004070001A2 Assay and compositions for detection of bacillus anthracis nucleic acid
08/19/2004WO2004069992A2 Oligomeric compounds for the modulation of ras expression
08/19/2004WO2004069850A2 Switchable nucleic acids for diagnostics, screening and molecular electronics
08/19/2004WO2004069849A2 Bead emulsion nucleic acid amplification
08/19/2004WO2004069191A2 Identification of t1r and t2r modulators
08/19/2004WO2004069189A2 Methods of assessment of drug metabolizing enzymes
08/19/2004WO2004069152A2 Δ4,5 glycuronidase and uses thereof
08/19/2004WO2004069148A2 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids
08/19/2004WO2004055117A3 Carboxamide-substituted dyes for analytical applications
08/19/2004WO2004034991A3 Antisense modulation of fatty acid synthase expression
08/19/2004WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases
08/19/2004WO2004017909A3 Methods of reducing ischemic injury
08/19/2004WO2004016805A9 Immunostimulatory nucleic acids
08/19/2004WO2004016215A3 Use of antisense oligonucleotides to inhibit the expression of akt-1
08/19/2004WO2004003136A3 Methods of detecting sequence differences
08/19/2004WO2003087166A3 Photoactivatable silane compounds and methods for their synthesis and use
08/19/2004WO2003078450A3 Negatively charged minor groove binders
08/19/2004WO2003066880A3 Method for accessing microbial diversity
08/19/2004WO2003060084A3 Methods for making polynucleotides and purifying double-stranded polynucleotides